DC3 Therapeutics, LLC

South San Francisco, CA

UEI
EHDBBFU1ER95
CAGE
994D2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
  • Black American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
163 W Harris Ave, South San Francisco, CA 94080, USA
Founded
2013
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $24,400

Contract awards

Quick answers

Is DC3 Therapeutics, LLC registered in SAM.gov?

Yes. DC3 Therapeutics, LLC's SAM.gov registration is active through May 30, 2027.

How much has DC3 Therapeutics, LLC received in federal contracts?

Federal contracts obligated $24,400 to DC3 Therapeutics, LLC in fiscal year 2025.

What is DC3 Therapeutics, LLC's most recent federal award?

DC3 Therapeutics, LLC's most recent federal contract award is Research testing for long covid period of performance 08/01/2025-09/30/2025 (36C26125P1359), from Veterans Integrated Service Network 21 (VHA), on August 1, 2025.

On GovTribe

See DC3 Therapeutics, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors